These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25661374)

  • 21. Down-regulation of miR-5702 is associated with clinical progression and poor prognosis in patients with non-small-cell lung cancer.
    Li K; Xu Y; Yuan LN
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2047-2052. PubMed ID: 30915748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.
    Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L
    Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
    Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J
    Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.
    Qian L; Ji AH; Zhang WJ; Zhao N
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):430-442. PubMed ID: 29424924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
    Yu SH; Zhang CL; Dong FS; Zhang YM
    J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer.
    Wang Y; Li J; Chen H; Mo Y; Ye H; Luo Y; Guo K; Mai Z; Zhang Y; Chen B; Zhou Y; Yang Z
    Gene; 2016 Oct; 591(2):333-7. PubMed ID: 27282282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
    PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer.
    Wang R; Ye F; Zhen Q; Song T; Tan G; Chu W; Zhang Y; Lv B; Zhao X; Liu J
    J Physiol Biochem; 2016 Jun; 72(2):337-43. PubMed ID: 27083571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer.
    Tang R; Liang L; Luo D; Feng Z; Huang Q; He R; Gan T; Yang L; Chen G
    Med Sci Monit; 2015 Aug; 21():2514-20. PubMed ID: 26305739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
    Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
    J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA-146 up-regulation predicts the prognosis of non-small cell lung cancer by miRNA in situ hybridization.
    Li J; Yang H; Li Y; Liu Y; Chen S; Qi C; Zhang Q; Lan T; He X; Guan XY; Wang L
    Exp Mol Pathol; 2014 Apr; 96(2):195-9. PubMed ID: 24448024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells.
    Ke Y; Zhao W; Xiong J; Cao R
    FEBS Lett; 2013 Sep; 587(18):3153-7. PubMed ID: 23954293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.
    Zhu WY; Luo B; An JY; He JY; Chen DD; Xu LY; Huang YY; Liu XG; Le HB; Zhang YK
    Cancer Invest; 2014 Oct; 32(8):394-401. PubMed ID: 24945821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-361-5p associates with aggressive clinicopathological features and unfavorable prognosis in non-small cell lung cancer.
    Zhuang ZL; Tian FM; Sun CL
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5132-5136. PubMed ID: 28051257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
    Wu DW; Cheng YW; Wang J; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
    Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
    Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer.
    Jiang LP; Zhu ZT; He CY
    Future Oncol; 2016 May; 12(9):1105-15. PubMed ID: 27033050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer.
    Gao W; Lu X; Liu L; Xu J; Feng D; Shu Y
    Cancer Biol Ther; 2012 Mar; 13(5):330-40. PubMed ID: 22237007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.